Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×

watch

Synergy Pharmaceuticals, Inc.

Sector: Commercial Physical And Biological Research Region: NY, United States


Exchange/Ticker: Nasdaq: SGYP | Nasdaq: SGYPW | Nasdaq: SGYPU


Company Description

Synergy Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of drugs to treat gastrointestinal disorders and diseases. Its proprietary drug candidate Plecanatide is a synthetic analog of the human gastrointestinal hormone uroguanylin, and functions by activating the Guanylate Cyclase C receptor on epithelial cells of the GI tract. The company was founded on November 15, 2005 and is headquartered in New York, NY.

Similar to: Medivir AB, Advanced Cell Technology, Inc., Exelixis, Inc.

Featured Company


Fidelity Asian Values Plc

Tadworth, SU, GB

Fidelity Asian Values Plc is a Closed-End Investment Fund/Investment. The company invests in information technology, energy, financial… Learn more →

You may also be interested in:


Exelixis, Inc.

South San Francisco, CA, US

Exelixis, Inc. develops human therapeutics by innovating therapies for cancer and other serious diseases to various pharmaceutical… Learn more →

Advanced Cell Technology,…

Marlborough, MA, US

Advanced Cell Technology, Inc. is a biotechnology company that develops cellular therapies for the treatment of rare and common diseases… Learn more →

Medivir AB

Stockholm, SE

Medivir is a research based pharmaceutical company focused on infectious diseases and Nordic market presences were we market 15 products… Learn more →